Global Injection Pen Market Size, Industry Trends, Share and Forecast 2020-2026

The global injection pen market is anticipated to grow at a CAGR of 6.8% over the forecast period (2020-2026). The market is segmented on the basis of type and disorder type. Based on the disorder type, the market is segmented into diabetes, hormonal disorders, arthritis, and others. The diabetes segment of the market is estimated to witness significant growth in the market. The key aspects that drive the segmental growth of the injection pen market include the increased incidences of autoimmune disorders primarily diabetes and arthritis among the people across the globe.

Request a Free Sample of our Global Injection Pen Market: https://www.omrglobal.com/request-sample/injection-pen-market

There has been an upsurge witnessed in the prevalence of diabetes across the globe. As per the WHO, diabetes prevalence has been increasing steadily over the past three decades. In 2019, the diabetic population was nearly 463 million which is expected to rise to 578 million by 2030 as per the IDF, which will further raise to 700 million by 2045. These numbers specify an increase in the prevalence of diabetes which will demand the proper treatment options including insulin. Thus, owing to the higher demand for safe insulin delivery devices, the segment is likely to witness an upsurge over the forecast period.

A full Report of Global Injection Pen Market is Available at: https://www.omrglobal.com/industry-reports/injection-pen-market

Market Coverage

• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and By Disorder Type
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Eli Lily & Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., Becton, Dickinson & Co., Novo Nordisk A/S, Owen Mumford Ltd., and AstraZeneca Plc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Injection Pen Market – Segmentation

By Type

• Reusable
• Disposable

By Disorder Type

• Autoimmune Disorders
• Hormonal Disorders
• Orphan Diseases
• Others

Global Injection Pen Market – Segmentation by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AstraZeneca Plc
• Bayer AG
• Becton, Dickinson & Co.
• Biocorp Production SA
• Copernicus
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Gerresheimer AG
• Haselmeier GmbH
• Merck KGaA
• Mylan N.V.
• Novartis International AG
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Pfizer Inc.
• Sanofi SA
• Solteam Incorporation Co., Ltd.
• Ypsomed Holding AG

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/injection-pen-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.